65 results
Page 2 of 4
8-K
EX-10.1
8lab47d0ow88d8krn1
2 Aug 23
ABVC Signs a Term Sheet to Earn Licensing Fees of up to $20M and Royalties of 5-12% of Net Sales
5:00pm
424B4
fkru844dyriobpx
12 Jun 23
Prospectus supplement with pricing info
4:30pm
POS AM
vzfoyuh zr28x65o3z
26 Apr 23
Prospectus update (post-effective amendment)
2:08pm
POS AM
jhy92oo 608i88bhclxu
26 Apr 23
Prospectus update (post-effective amendment)
1:29pm
424B4
rken gmg1
11 Jul 22
Prospectus supplement with pricing info
4:01pm
424B3
vmqcdrimt ihn6
11 Jul 22
Prospectus supplement
4:00pm
POS AM
smv7hndbdo9ht0sx6k7
14 Jun 22
Prospectus update (post-effective amendment)
5:29pm
POS AM
7nj4ycyu7dj2 0j9n
14 Jun 22
Prospectus update (post-effective amendment)
5:27pm
8-K
EX-1.1
rk6sqpf
12 May 22
Entry into a Material Definitive Agreement
8:30am
8-K
EX-1.1
xngr o3i3mawg
5 Aug 21
ABVC BioPharma, Inc. Announces Pricing of $6.875 Million Firm Commitment Offering
3:23pm
424B4
681b3ga9w6awbr8a 25
4 Aug 21
Prospectus supplement with pricing info
3:28pm